Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells

Abstract Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) is a potential redox agent in cells. The present study investigated changes in cellular reactive oxygen species (ROS) and glutathione (GSH) levels and in antioxidant enzymes, in Tempol-treated Calu-6 and A549 lung cancer cells, normal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Woo Hyun Park
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d8c46cc274cb45c498ea690ce243b174
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d8c46cc274cb45c498ea690ce243b174
record_format dspace
spelling oai:doaj.org-article:d8c46cc274cb45c498ea690ce243b1742021-12-02T17:55:13ZTempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells10.1038/s41598-021-94340-z2045-2322https://doaj.org/article/d8c46cc274cb45c498ea690ce243b1742021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94340-zhttps://doaj.org/toc/2045-2322Abstract Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) is a potential redox agent in cells. The present study investigated changes in cellular reactive oxygen species (ROS) and glutathione (GSH) levels and in antioxidant enzymes, in Tempol-treated Calu-6 and A549 lung cancer cells, normal lung WI-38 VA-13 cells, and primary pulmonary fibroblasts. Results demonstrated that Tempol (0.5–4 mM) either increased or decreased general ROS levels in lung cancer and normal cells at 48 h and specifically increased O2 •− levels in these cells. In addition, Tempol differentially altered the expression and activity of antioxidant enzymes such as superoxide dismutase, catalase, and thioredoxin reductase1 (TrxR1) in A549, Calu-6, and WI-38 VA-13 cells. In particular, Tempol treatment increased TrxR1 protein levels in these cells. Tempol at 1 mM inhibited the growth of lung cancer and normal cells by about 50% at 48 h but also significantly induced cell death, as evidenced by annexin V-positive cells. Furthermore, down-regulation of TrxR1 by siRNA had some effect on ROS levels as well as cell growth inhibition and death in Tempol-treated or -untreated lung cells. In addition, some doses of Tempol significantly increased the numbers of GSH-depleted cells in both cancer cells and normal cells at 48 h. In conclusion, Tempol differentially increased or decreased levels of ROS and various antioxidant enzymes in lung cancer and normal cells, and induced growth inhibition and death in all lung cells along with an increase in O2 •− levels and GSH depletion.Woo Hyun ParkNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Woo Hyun Park
Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
description Abstract Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) is a potential redox agent in cells. The present study investigated changes in cellular reactive oxygen species (ROS) and glutathione (GSH) levels and in antioxidant enzymes, in Tempol-treated Calu-6 and A549 lung cancer cells, normal lung WI-38 VA-13 cells, and primary pulmonary fibroblasts. Results demonstrated that Tempol (0.5–4 mM) either increased or decreased general ROS levels in lung cancer and normal cells at 48 h and specifically increased O2 •− levels in these cells. In addition, Tempol differentially altered the expression and activity of antioxidant enzymes such as superoxide dismutase, catalase, and thioredoxin reductase1 (TrxR1) in A549, Calu-6, and WI-38 VA-13 cells. In particular, Tempol treatment increased TrxR1 protein levels in these cells. Tempol at 1 mM inhibited the growth of lung cancer and normal cells by about 50% at 48 h but also significantly induced cell death, as evidenced by annexin V-positive cells. Furthermore, down-regulation of TrxR1 by siRNA had some effect on ROS levels as well as cell growth inhibition and death in Tempol-treated or -untreated lung cells. In addition, some doses of Tempol significantly increased the numbers of GSH-depleted cells in both cancer cells and normal cells at 48 h. In conclusion, Tempol differentially increased or decreased levels of ROS and various antioxidant enzymes in lung cancer and normal cells, and induced growth inhibition and death in all lung cells along with an increase in O2 •− levels and GSH depletion.
format article
author Woo Hyun Park
author_facet Woo Hyun Park
author_sort Woo Hyun Park
title Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_short Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_full Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_fullStr Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_full_unstemmed Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
title_sort tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d8c46cc274cb45c498ea690ce243b174
work_keys_str_mv AT woohyunpark tempoldifferentlyaffectscellularredoxchangesandantioxidantenzymesinvariouslungrelatedcells
_version_ 1718379137180106752